Respiratory Failure and Advanced Respiratory Emergencies - NREMT Paramedic Level

SECTION 1

Historical Context & Motivation

The understanding of respiratory failure has evolved dramatically over several centuries, transforming from rudimentary observations of drowning victims to a sophisticated, evidence-based framework that guides modern prehospital care. Early physicians recognized that cessation of breathing led to death, yet lacked the physiological understanding to intervene meaningfully. The development of mechanical ventilation, pulse oximetry, and arterial blood gas analysis in the twentieth century fundamentally changed the way clinicians classify, recognize, and treat respiratory emergencies. For the paramedic, this historical trajectory matters because it underpins every protocol used to manage a patient in acute respiratory distress—from bag-valve-mask ventilation to rapid-sequence intubation.

1543 • Vesalius Demonstrates Positive-Pressure Ventilation

Andreas Vesalius showed that inserting a reed into the trachea of an animal and blowing air could sustain life, establishing the principle that external ventilation could replace spontaneous breathing—a concept central to modern airway management.

1929 • The Iron Lung Era

Philip Drinker and Louis Shaw developed the iron lung, a negative-pressure ventilator that sustained thousands of polio patients with respiratory muscle paralysis and sparked systematic study of ventilatory failure.

1967 • ARDS Described

Ashbaugh and colleagues published the landmark description of acute respiratory distress syndrome (ARDS), distinguishing a pattern of non-cardiogenic pulmonary edema with refractory hypoxemia that demanded new ventilatory strategies.

1983 • Pulse Oximetry Enters Clinical Practice

Non-invasive pulse oximetry became widely available, enabling real-time monitoring of oxygen saturation in the field and fundamentally changing prehospital detection of hypoxemia.

2010s • Waveform Capnography Standard of Care

End-tidal CO₂ monitoring via waveform capnography became standard for paramedics, providing continuous assessment of ventilation status, tube placement confirmation, and perfusion adequacy.

Despite these advances, respiratory emergencies remain the leading cause of prehospital cardiac arrest in pediatric populations and a primary driver of morbidity in adult patients. The central question this lesson addresses is: How does a paramedic systematically identify the type and severity of respiratory failure and select the appropriate intervention before irreversible organ damage occurs?

SECTION 2

Core Principles & Definitions

Respiratory failure occurs when the pulmonary system is unable to maintain adequate gas exchange to meet the metabolic demands of the body. Before dissecting the types and stages of failure, it is essential to distinguish several related but distinct clinical states. Respiratory distress denotes a condition in which the patient is working harder than normal to breathe—tachypnea, accessory muscle use, and anxiety are hallmarks—but is still compensating effectively enough to maintain acceptable oxygenation and ventilation. Respiratory failure marks the point at which compensatory mechanisms have been exhausted and the patient can no longer sustain adequate PaO₂ or eliminate CO₂ at a rate that prevents acidosis. Finally, respiratory arrest is the complete cessation of breathing, which, without immediate intervention, progresses to cardiac arrest within minutes.

Type I — Hypoxemic Failure

Defined by PaO₂ < 60 mmHg on room air with a normal or low PaCO₂. The primary defect is impaired oxygenation due to V/Q mismatch, shunt, diffusion impairment, or low FiO₂. Classic causes include pneumonia, pulmonary embolism, ARDS, and pulmonary edema.

Type II — Hypercapnic Failure

Characterized by PaCO₂ > 45 mmHg with associated respiratory acidosis. The primary defect is inadequate alveolar ventilation—the patient cannot move enough air. Causes include COPD exacerbation, neuromuscular disease, drug overdose, and chest wall deformity.

Type III — Perioperative / Atelectatic

Results from progressive alveolar collapse, commonly seen post-anesthesia or in splinting from rib fractures. Low functional residual capacity causes widespread atelectasis and subsequent hypoxemia. This is relevant in trauma patients immobilized on long boards.

Type IV — Shock-Associated

Occurs when hypoperfusion impairs respiratory muscle function and metabolic demands exceed oxygen delivery. Seen in cardiogenic, hypovolemic, and distributive shock states. Respiratory muscles consume a disproportionate share of cardiac output, worsening the overall shock picture.

✦

KEY TAKEAWAY

Think of the respiratory system as a two-stage pump. Stage one is the ventilatory bellows—the chest wall, diaphragm, and airways that move air in and out. Stage two is the gas-exchange membrane at the alveolar-capillary interface. Type II failure is a broken bellows; Type I failure is a damaged membrane. Both lead to the same catastrophic endpoint—tissue hypoxia—but they demand different interventions. As a paramedic, your first job is to determine which stage is failing.

SECTION 3

Visual Explanation — The Continuum of Respiratory Compromise

This diagram illustrates the four stages of respiratory compromise—distress, early failure, late failure, and arrest—mapped against key clinical indicators (SpO₂, EtCO₂, mental status) and the escalating interventions appropriate at each stage.

The clinical significance of this continuum lies in recognizing that respiratory distress is a warning, not yet a crisis. A patient with tachypnea, accessory muscle use, and an SpO₂ of 93% is still compensating—this is the optimal window for intervention. Once compensatory mechanisms fail and the patient crosses into true respiratory failure, the margin for error narrows dramatically. Notice that mental status serves as a particularly sensitive indicator: agitation and confusion in a dyspneic patient frequently herald the transition from distress to failure, because the brain is exquisitely sensitive to both hypoxemia and hypercapnia. In the prehospital environment, a declining level of consciousness in a patient with breathing difficulty should trigger immediate reassessment and preparation for assisted ventilation.

SECTION 4

Pathophysiological Mechanisms of Respiratory Failure

Understanding the mechanisms that produce respiratory failure enables the paramedic to choose targeted interventions rather than relying on a one-size-fits-all approach. Four principal pathophysiological mechanisms account for the vast majority of acute respiratory failure encountered in the field.

V/Q Mismatch

Ventilation-perfusion (V/Q) mismatch is the most common cause of hypoxemia. In an ideal lung, every alveolus receives proportional airflow and blood flow. The normal V/Q ratio is approximately 0.8, reflecting a minute ventilation of about 4 L/min and a cardiac output of 5 L/min. When regions of lung are ventilated but not perfused (as in pulmonary embolism, creating dead space) or perfused but not ventilated (as in atelectasis or pneumonia, creating shunt), gas exchange becomes inefficient. The hallmark is that V/Q mismatch responds at least partially to supplemental oxygen, unlike true shunt.

ALVEOLAR GAS EQUATION (SIMPLIFIED)

PAO₂ = FiO₂ × (Pᵦ − PH₂O) − (PaCO₂ / R)

Where PAO₂ = alveolar partial pressure of O₂, FiO₂ = fraction of inspired oxygen, Pᵦ = barometric pressure (760 mmHg at sea level), PH₂O = water vapor pressure (47 mmHg at 37°C), PaCO₂ = arterial CO₂, and R = respiratory quotient (≈ 0.8). This equation helps predict the expected alveolar oxygen level and calculate the A-a gradient (PAO₂ − PaO₂), which distinguishes hypoventilation (normal gradient) from V/Q mismatch or shunt (widened gradient).

Intrapulmonary Shunt

A true intrapulmonary shunt occurs when blood passes through the pulmonary vasculature without participating in gas exchange—alveoli are completely collapsed or fluid-filled. Unlike V/Q mismatch, shunt physiology produces hypoxemia that is refractory to supplemental oxygen because the shunted blood never contacts ventilated alveoli. ARDS and massive pneumonia are prototypical causes. In the field, if a patient's SpO₂ does not improve with high-flow oxygen, the paramedic should suspect significant shunt and prepare for positive-pressure ventilation (CPAP or intubation) to recruit collapsed alveoli.

Hypoventilation

Hypoventilation reduces alveolar minute ventilation, causing CO₂ accumulation and secondary hypoxemia. The alveolar gas equation shows that as PaCO₂ rises, PAO₂ must fall if FiO₂ remains constant. Causes include opioid overdose, neuromuscular disease (e.g., Guillain-Barré syndrome), and severe obesity. The A-a gradient remains normal because the gas-exchange membrane is intact—the patient simply is not moving enough air. Treatment targets the underlying cause (e.g., naloxone for opioid overdose) while providing ventilatory support.

MINUTE VENTILATION

V̇E = VT × f

Where V̇E = minute ventilation (L/min), VT = tidal volume (mL or L per breath), and f = respiratory rate (breaths/min). Effective alveolar ventilation = (VT − VD) × f, where VD = dead space volume (≈ 150 mL in adults). This explains why rapid, shallow breathing (high f, low VT) can produce dangerously low alveolar ventilation despite normal or elevated minute ventilation.

Diffusion Impairment

When the alveolar-capillary membrane thickens due to fibrosis, edema, or inflammatory infiltrate, the rate of oxygen diffusion into the bloodstream decreases. Under resting conditions, the transit time for red blood cells through pulmonary capillaries (≈ 0.75 seconds) normally provides ample time for equilibration. However, with a thickened membrane, equilibrium may not be reached, particularly during exertion or tachycardia when transit time shortens. Prehospitally, diffusion impairment manifests as exercise-induced or positional hypoxemia that often responds to supplemental oxygen at rest.

💡

Clinical Pearl

A quick bedside test: if the patient's SpO₂ improves significantly with a non-rebreather mask, the mechanism is likely V/Q mismatch, hypoventilation, or diffusion impairment. If SpO₂ remains stubbornly low despite high-flow O₂, suspect significant shunt and prepare for positive-pressure ventilation with PEEP.

SECTION 5

Classification of Advanced Respiratory Emergencies

At the paramedic level, you will encounter a range of advanced respiratory emergencies that require rapid differential diagnosis and condition-specific management. These emergencies can be organized by anatomical location and mechanism into upper airway, lower airway, parenchymal, pleural, and extrapulmonary categories. The following diagram and table provide a systematic classification framework.

An anatomical classification tree for respiratory emergencies, showing the five major categories—upper airway, lower airway, parenchymal, pleural, and extrapulmonary—with characteristic conditions and auscultatory findings for each.

Category	Key Assessment Findings	Primary Prehospital Interventions
Upper Airway	Inspiratory stridor, drooling, voice changes, tripod positioning, visible swelling or foreign body	Epinephrine (anaphylaxis), nebulized racemic epinephrine (croup), direct/video laryngoscopy, surgical airway if complete obstruction
Lower Airway	Expiratory wheezing, prolonged expiratory phase, air trapping, hyperinflation, diminished air movement in severe cases	Inhaled β₂-agonists (albuterol), ipratropium, IV/IM magnesium sulfate, CPAP, IV corticosteroids, epinephrine for severe asthma
Parenchymal	Bilateral crackles/rales, refractory hypoxemia, frothy sputum (pulmonary edema), fever (pneumonia), diffuse infiltrates	CPAP/BiPAP, high-flow O₂, nitroglycerin (CHF), positioning, intubation with PEEP for ARDS
Pleural	Unilateral absent/diminished breath sounds, tracheal deviation (tension), subcutaneous emphysema, JVD, hypotension	Needle decompression (tension pneumothorax), occlusive dressing (open pneumothorax), fluid resuscitation (hemothorax)
Extrapulmonary	Shallow/slow respirations, clear lungs on auscultation, CNS depression, paradoxical chest wall movement (flail chest)	BVM-assisted ventilation, naloxone (opioid OD), splinting (flail chest), RSI and intubation for prolonged hypoventilation

Summary of assessment findings and interventions by respiratory emergency category

SECTION 6

Worked Example — Systematic Assessment of a Dyspneic Patient

Consider the following scenario: You respond to a 68-year-old male sitting upright in a recliner, awake but confused and diaphoretic. He has a history of COPD and congestive heart failure. His wife reports increasing shortness of breath over 2 days with worsening tonight. Vital signs: HR 118, RR 32, BP 178/100, SpO₂ 82% on room air, temperature 37.9°C. Lung sounds reveal bilateral crackles to the midlung fields with expiratory wheezing at the bases. He is speaking in 2- to 3-word sentences. EtCO₂ on nasal cannula reads 58 mmHg with a shark-fin waveform.

Systematic Assessment and Management

1
Step 1 — Determine Position on Respiratory Continuum

The patient demonstrates SpO₂ of 82%, EtCO₂ of 58 mmHg, confusion, tachypnea at 32, and inability to speak in full sentences. These findings place him in late respiratory failure—well past the compensatory distress stage. He is hypoxemic (Type I component) AND hypercapnic (Type II component), indicating mixed respiratory failure.

Late respiratory failure — mixed Type I and Type II
2
Step 2 — Identify Anatomical Category

Bilateral crackles suggest a parenchymal process (pulmonary edema consistent with his CHF history). The expiratory wheezing and shark-fin capnography waveform indicate a concurrent lower airway component (bronchospasm, likely from his COPD). The elevated BP and bilateral findings argue against a pleural or extrapulmonary cause.

Combined parenchymal (CHF exacerbation) + lower airway (COPD exacerbation)
3
Step 3 — Calculate A-a Gradient (Conceptual)

Using the simplified alveolar gas equation on room air (FiO₂ = 0.21): PAO₂ = 0.21 × (760 − 47) − (58 / 0.8) = 0.21 × 713 − 72.5 = 149.7 − 72.5 = 77.2 mmHg. With the patient's SpO₂ at 82%, estimated PaO₂ ≈ 50 mmHg (from the oxyhemoglobin dissociation curve). A-a gradient ≈ 77.2 − 50 = 27.2 mmHg. This is significantly widened (normal for age ≈ (68/4) + 4 = 21 mmHg), confirming a V/Q mismatch or shunt component in addition to the hypoventilation from the elevated PaCO₂.

A-a gradient ≈ 27 mmHg (widened) — confirms intrinsic lung pathology beyond simple hypoventilation
4
Step 4 — Initiate Targeted Interventions

The dual pathology demands a multi-pronged approach. First, apply CPAP at 5–10 cmH₂O with high-flow oxygen—this simultaneously recruits flooded alveoli (treating the parenchymal edema) and stents open collapsing airways (treating the bronchospasm). Administer inline nebulized albuterol through the CPAP circuit. Give sublingual nitroglycerin to reduce preload (the elevated BP supports this). Establish IV access and prepare for possible intubation if the patient deteriorates.

CPAP + O₂ + albuterol + nitroglycerin — reassess in 5 minutes
5
Step 5 — Reassess and Trend

After 5 minutes of CPAP: SpO₂ rises to 91%, EtCO₂ decreases to 48 mmHg, RR drops to 26, and the patient becomes less confused—he can now state his name. The improving trend suggests the interventions are effective and the patient is moving leftward on the respiratory continuum from late failure toward early failure/distress. Continue CPAP, monitor waveform capnography for improving shark-fin morphology, and prepare for potential titration to BiPAP if CO₂ remains elevated.

Improving — continue current therapy, monitor trends, prepare for escalation if needed

SECTION 7

Comparison of Ventilatory Interventions

Paramedics have a range of ventilatory interventions at their disposal, from simple supplemental oxygen to definitive airway management. Selecting the right tool at the right time is critical—over-intervening can cause harm (e.g., intubating a patient who would have responded to CPAP), while under-intervening can be fatal. The following comparison highlights the strengths and limitations of the primary ventilatory modalities available in the prehospital setting.

Intervention	Strengths	Limitations
Nasal Cannula / NRB Mask	Non-invasive, well-tolerated, rapid application. NRB delivers FiO₂ ≈ 0.85–0.95. Low skill requirement.	Cannot provide positive pressure. Useless in apnea. NRB requires adequate respiratory effort. Does not address ventilation failure.
CPAP	Non-invasive positive pressure. Recruits atelectatic alveoli, reduces work of breathing, decreases preload in CHF. Rapid setup. Can deliver inline nebulizers.	Requires conscious, cooperative patient with intact airway reflexes. Cannot be used in apnea. Contraindicated with pneumothorax, vomiting, facial trauma.
BVM Ventilation	Provides positive-pressure ventilation in apnea or near-apnea. Universally available. Can be used as bridge to intubation. Allows hyperventilation if needed.	Difficult to maintain seal, especially with facial hair or edentulous patients. Risk of gastric insufflation and aspiration. Operator fatigue. Two-person technique optimal.
Supraglottic Airway (SGA)	Easier insertion than ETT. No laryngoscope required. Good seal for ventilation. Can be placed blindly. Useful in difficult airway or cardiac arrest.	Does not protect against aspiration (partial protection with second-generation devices). Not definitive airway. May dislodge during transport. Size selection critical.
Endotracheal Intubation	Definitive airway with cuff seal. Protects against aspiration. Allows precise FiO₂ and PEEP delivery. Enables suctioning. Gold standard for prolonged ventilation.	Requires advanced skill and ongoing practice. Risk of esophageal intubation. Hypoxia during prolonged attempts. RSI medications carry hemodynamic risks. Must confirm placement with waveform capnography.
Surgical Cricothyrotomy	Rescue airway when all other methods fail. Bypasses upper airway obstruction. Can be performed in 30–60 seconds by trained providers.	Invasive and irreversible. Rarely practiced in the field. Complications include hemorrhage, false passage, and subcutaneous emphysema. Contraindicated in children < 10–12 years.

Comparison of prehospital ventilatory interventions

✦

KEY TAKEAWAY

Think of airway interventions as a ladder, not a menu. You start at the lowest rung that addresses the patient's pathology and only climb higher if the patient's condition demands it. A conscious COPD patient in failure may need only CPAP, while an obtunded overdose patient requires BVM ventilation and intubation. The critical error is not matching the intervention to the stage and cause of failure. CPAP on an apneic patient is futile; intubating a patient who would have responded to CPAP introduces unnecessary procedural risk.

SECTION 8

Connection to Advanced Theory — Ventilator Strategy and Post-Intubation Management

Once a paramedic secures a definitive airway, the management challenge shifts from gaining airway control to optimizing ventilation strategy—a domain that bridges prehospital and critical care medicine. Understanding the principles of post-intubation management is increasingly emphasized at the paramedic level, particularly as transport ventilators and protocols become more sophisticated. The following table compares basic prehospital ventilation targets with the more nuanced strategies used in critical care, illustrating how field decisions set the stage for hospital management.

Parameter	Prehospital Standard	ICU / Advanced Strategy
Tidal Volume	6–8 mL/kg ideal body weight (IBW)	4–8 mL/kg IBW; lung-protective ventilation (≤ 6 mL/kg) standard in ARDS
Rate	10–12 breaths/min (adults); adjusted by EtCO₂	12–20 breaths/min; permissive hypercapnia accepted in ARDS to limit plateau pressure
PEEP	5 cmH₂O default if transport vent available	5–20 cmH₂O titrated to oxygenation/compliance; higher PEEP tables for ARDS
FiO₂	1.0 initially; titrate to SpO₂ ≥ 94% (≥ 88% in COPD)	Titrate to lowest FiO₂ maintaining SpO₂ 88–95%; oxygen toxicity concern > 0.6 prolonged
EtCO₂ Target	35–45 mmHg; avoid hyperventilation	Patient-specific; permissive hypercapnia (PaCO₂ up to 60–80) may be tolerated in ARDS or severe asthma
Sedation	Post-intubation sedation per protocol (midazolam, ketamine, fentanyl)	Richmond Agitation-Sedation Scale (RASS) targeted sedation; daily awakening trials

Prehospital vs. ICU ventilation parameters

A critical concept gaining traction in prehospital medicine is peri-intubation cardiovascular collapse. Patients in respiratory failure often present with compensatory catecholamine surges that maintain blood pressure. When sedation and paralysis remove sympathetic drive and positive-pressure ventilation decreases venous return, profound hypotension or cardiac arrest can occur within minutes of intubation. This has led to the development of delayed sequence intubation (DSI) and hemodynamic optimization bundles (push-dose vasopressors, fluid boluses, apneic oxygenation) that are now appearing in progressive paramedic protocols. Understanding these concepts prepares you for the evolving scope of prehospital critical care.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A patient with severe asthma presents with audible wheezing that suddenly disappears as the patient becomes more lethargic. Is this an improvement or a deterioration? Explain the pathophysiological significance of a 'silent chest' in the context of the respiratory failure continuum.

Show answer

This represents a critical deterioration, not an improvement. The disappearance of wheezing—a 'silent chest'—indicates that air movement has become so severely reduced that there is insufficient flow through narrowed airways to generate the turbulence that produces wheezing. The patient has transitioned from respiratory distress into late respiratory failure and is approaching respiratory arrest. The lethargy confirms hypercapnia and/or severe hypoxemia affecting the central nervous system. This patient requires immediate assisted ventilation with BVM, preparation for intubation, and aggressive bronchodilator therapy. The clinical pearl: 'better wheezing than silence' reflects the fact that audible breath sounds, even pathological ones, confirm that air is moving.

Question 2: BASIC CALCULATION

A 70 kg patient with opioid overdose is breathing at a rate of 6 breaths/min with an estimated tidal volume of 200 mL. Calculate the patient's minute ventilation and alveolar ventilation (assume dead space = 150 mL). Is this patient in respiratory failure? What type?

Show answer

Minute ventilation (V̇E) = VT × f = 200 mL × 6 = 1,200 mL/min (1.2 L/min). This is drastically below the normal 6–8 L/min. Alveolar ventilation = (VT − VD) × f = (200 − 150) × 6 = 50 × 6 = 300 mL/min. Normal alveolar ventilation is approximately 4,200 mL/min (350 mL × 12). At only 300 mL/min of effective alveolar ventilation, CO₂ elimination is profoundly impaired. This patient is in Type II (hypercapnic) respiratory failure due to CNS-depressant-induced hypoventilation. The A-a gradient would be expected to be normal because the lung parenchyma is intact—the problem is purely ventilatory. Immediate interventions include naloxone administration and BVM-assisted ventilation.

Question 3: INTERMEDIATE

You apply a non-rebreather mask at 15 L/min to a patient with pneumonia and bilateral crackles. After 10 minutes, SpO₂ remains at 84%. What does this refractory hypoxemia suggest about the underlying pathophysiology? What is your next intervention, and why?

Show answer

Refractory hypoxemia despite high-flow supplemental oxygen strongly suggests significant intrapulmonary shunt. In pneumonia with bilateral crackles, the alveoli are filled with inflammatory exudate and fluid, causing blood to flow past non-ventilated alveoli. Increasing FiO₂ cannot correct shunt because the oxygen never reaches the flooded alveoli. The next intervention is CPAP (if the patient is conscious and protecting their airway) or positive-pressure ventilation with PEEP (if the patient requires intubation). PEEP recruits collapsed or fluid-filled alveoli by maintaining positive pressure at end-expiration, converting shunt units back into functional V/Q units. This is why PEEP is the definitive treatment for shunt-based hypoxemia, while increasing FiO₂ alone is insufficient.

Question 4: APPLIED

You are treating a 45-year-old female in anaphylaxis with progressive stridor, facial swelling, and SpO₂ of 88%. You administer IM epinephrine 0.3 mg and begin nebulized epinephrine. Despite treatment, stridor worsens and the patient can no longer vocalize. Your first intubation attempt fails due to severe edema. Describe your decision-making pathway for the next 2 minutes.

Show answer

This patient has a rapidly progressive upper airway emergency with imminent complete obstruction. After a failed intubation attempt in the setting of severe angioedema, you face a classic 'cannot intubate' scenario. Your decision pathway should proceed as follows: First, make one more attempt with optimized technique—consider a smaller endotracheal tube (6.0), video laryngoscopy if available, and a bougie. Simultaneously, have a partner prepare for surgical cricothyrotomy. If the second attempt fails, proceed immediately to surgical airway—do not delay for additional oral attempts. Throughout this process, continue BVM ventilation attempts between procedures, administer a second dose of IM epinephrine (if > 5 minutes since the first), and consider IV epinephrine infusion. A supraglottic airway may provide temporary ventilation as a bridge, though it is unlikely to bypass supraglottic swelling. The key principle: in a 'can't intubate, can't oxygenate' scenario, surgical cricothyrotomy is the rescue—delay is the enemy.

Question 5: CRITICAL THINKING

A 58-year-old COPD patient with a baseline SpO₂ of 90% on home O₂ is found in acute distress with SpO₂ of 78% and EtCO₂ of 72 mmHg. A colleague argues that aggressive oxygenation should be avoided because 'high-flow oxygen will knock out the hypoxic drive and cause apnea.' Critically evaluate this claim. What is the current evidence-based approach, and how do you balance the risks of hyperoxia against the immediate threat of hypoxemia?

Show answer

The 'hypoxic drive' theory—that supplemental oxygen will eliminate the respiratory drive in COPD patients—is an oversimplification that has been responsible for undertreating critically hypoxemic patients. While it is true that chronic CO₂ retainers have a blunted central chemoreceptor response and rely more on peripheral chemoreceptors sensitive to PaO₂, the dominant mechanism of oxygen-induced hypercapnia in COPD is actually the Haldane effect and loss of hypoxic pulmonary vasoconstriction—not apnea. Hyperoxia causes hemoglobin to release CO₂ and redistributes blood flow to poorly ventilated lung units, worsening V/Q mismatch. That said, an SpO₂ of 78% represents life-threatening hypoxemia that will cause cardiac arrest far faster than any oxygen-induced CO₂ rise. The evidence-based approach is: never withhold oxygen from a critically hypoxemic patient. Provide high-flow oxygen immediately, target SpO₂ of 88–92% for known COPD patients, monitor EtCO₂ closely, and be prepared to assist ventilation with BVM or CPAP if the patient's respiratory drive or tidal volume decreases. The risk of undertreating hypoxemia far outweighs the risk of worsening hypercapnia, which can be managed with ventilatory support.

SUMMARY

Respiratory Failure and Advanced Respiratory Emergencies — Summary

Summary

Respiratory failure represents the point at which compensatory mechanisms can no longer sustain adequate gas exchange, and it is classified into Type I (hypoxemic) and Type II (hypercapnic) forms, with Types III and IV reflecting atelectatic and shock-associated variants. The four principal mechanisms—V/Q mismatch, intrapulmonary shunt, hypoventilation, and diffusion impairment—each produce hypoxemia through distinct pathways that demand targeted interventions. Recognizing a patient's position on the respiratory continuum from distress through failure to arrest, and correlating clinical findings with an anatomical classification (upper airway, lower airway, parenchymal, pleural, extrapulmonary), enables the paramedic to select the most appropriate intervention at the right time.

The paramedic's toolkit escalates from supplemental oxygen and positioning through CPAP/BiPAP and BVM ventilation to endotracheal intubation and surgical cricothyrotomy, with each step matched to the severity and mechanism of failure. Continuous monitoring with pulse oximetry and waveform capnography provides real-time feedback on oxygenation and ventilation, guiding intervention decisions and confirming their effectiveness. The overarching principle: intervene early, match the intervention to the pathology, and reassess continuously.